Viewing Study NCT06169202


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-05-17 @ 8:36 AM
Study NCT ID: NCT06169202
Status: RECRUITING
Last Update Posted: 2023-12-13
First Post: 2023-12-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients
Sponsor: China Medical University, China
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fruquintinib View
None Irinotecan View
None Capecitabine View
None Gastrointestinal Tumours View
Keywords: